HLA-A*0201 Tyrosinase Tetramer-YMDGTMSQV-APC

Catalog No:
MBL-TS-0019-2C
$1,575.00

Formerly Catalog No.: TB-0019-2

Browse all MBL products from our MBL products homepage.

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications
Application FC
Reactivity Human
Conjugation APC
Peptide Sequence YMDGTMSQV
Class Class I
Sequence Location 368-376
MHC Allele A*02:01
Documents & Links for HLA-A*0201 Tyrosinase Tetramer-YMDGTMSQV-APC
Datasheet HLA-A*0201 Tyrosinase Tetramer-YMDGTMSQV-APC Datasheet

Documents & Links for HLA-A*0201 Tyrosinase Tetramer-YMDGTMSQV-APC
Datasheet HLA-A*0201 Tyrosinase Tetramer-YMDGTMSQV-APC Datasheet

Citations for HLA-A*0201 Tyrosinase Tetramer-YMDGTMSQV-APC – 1 Found
Akiyama, Yasuto; Tanosaki, Ryuji; Inoue, Naoki; Shimada, Makiko; Hotate, Yukie; Yamamoto, Akifumi; Yamazaki, Naoya; Kawashima, Ichiro; Nukaya, Ikuei; Takesako, Kazutoh; Maruyama, Kouji; Takaue, Yoichi; Yamaguchi, Ken. Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells. Journal Of Translational Medicine. 2005;3(1):4.  PubMed